CHA News Article

FDA Issues Nationwide Recall of Products from Texas Compounding Pharmacy

The U.S. Food and Drug Administration (FDA) has issued a health advisory alert regarding the voluntary nationwide recall of all products for sterile use from Specialty Compounding, LLC, a pharmacy located in Cedar Park, TX. Recent reports of bacterial bloodstream infections — caused by Rhodococcus equi — are potentially related to the company’s calcium gluconate infusions, and two of the 15 affected patients have died. The California Department of Public Health (CDPH) is requesting incidents of any human isolation of Rhodococcus spp. from blood cultures since Feb. 1 be reported to kavita.trivedi@cdph.ca.gov. Background information and recommendations are available on the CDC website. The FDA press release is available on the FDA Safety web page.

Commands